Literature DB >> 6134652

Bacterial L-form isolation from inflammatory bowel disease patients.

M R Belsheim, R Z Darwish, W C Watson, B Schieven.   

Abstract

This study was designed to investigate a possible relationship between bacterial L forms and inflammatory bowel disease. Homogenates of intestinal mucosal biopsies from Crohn's disease, ulcerative colitis, and control patients underwent bacterial culture on hypertonic media designed for the recovery of L-form bacteria and parental organisms. L forms were recovered from 24 of 71 Crohn's disease, 51 of 121 ulcerative colitis, and 2 of 140 control biopsy specimens. These isolation rates are significantly different when Crohn's disease biopsy specimens (p less than 0.001) and ulcerative colitis biopsy specimens (p less than 0.001) are compared with controls. Six different L-form types were recovered, of which the most common were Escherichia coli and Streptococcus fecalis. No marked differences were observed in L-form recovery rates or L-form types recovered between Crohn's disease and ulcerative colitis patients. Drug treatment of inflammatory bowel disease patients did not affect L-form recovery rates or the type of L forms recovered. The results suggest either that L forms are involved in the causation of inflammatory bowel disease or that their presence in mucosal biopsy tissues is a result of the disease process.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134652

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

Review 1.  Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.

Authors:  Gert De Hertogh; Jeroen Aerssens; Karen P Geboes; Karel Geboes
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

2.  T-cellular immune reactions (in macrophage inhibition factor assay) against Mycobacterium paratuberculosis, Mycobacterium kansasii, Mycobacterium tuberculosis, Mycobacterium avium in patients with chronic inflammatory bowel disease.

Authors:  C A Seldenrijk; H A Drexhage; S G Meuwissen; C J Meijer
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

3.  Cell-wall deficient bacteria in inflammatory bowel disease.

Authors:  J P Ibbotson; P E Pease; R N Allan
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

Review 4.  The aetiology of Crohn's disease.

Authors:  G N Tytgat; C J Mulder
Journal:  Int J Colorectal Dis       Date:  1986-07       Impact factor: 2.571

5.  Investigation of mycobacteria in Crohn's disease tissue by Southern blotting and DNA hybridisation with cloned mycobacterial genomic DNA probes from a Crohn's disease isolated mycobacteria.

Authors:  P D Butcher; J J McFadden; J Hermon-Taylor
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

Review 6.  Crohn's disease: ancient and modern.

Authors:  M S Smith; A J Wakefield
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

7.  Proteins of 30 and 36 kilodaltons, membrane constituents of the Staphylococcus aureus L form, induce production of tumor necrosis factor alpha and activate the human immunodeficiency virus type 1 long terminal repeat.

Authors:  A Akashi; S Ono; K Kuwano; S Arai
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

8.  Spheroplastic phase of mycobacteria isolated from patients with Crohn's disease.

Authors:  R J Chiodini; H J Van Kruiningen; W R Thayer; J A Coutu
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

Review 9.  Innate immunity in inflammatory bowel disease: a disease hypothesis.

Authors:  D J B Marks; A W Segal
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

10.  Induction of macrophage-mediated production of tumor necrosis factor alpha by an L-form derived from Staphylococcus aureus.

Authors:  K Kuwano; A Akashi; I Matsu-ura; M Nishimoto; S Arai
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.